Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update on JIML

5 May 2026 07:00

RNS Number : 9084C
Jarvis Securities plc
05 May 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update on JIML

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, (the "Transaction"). In order to deliver optimal value for shareholders, the Company has engaged S&W Partners LLP to explore the possibility of a sale of JIML. (the "Potential Disposal"). The Potential Disposal will be subject to conditions set out below and there can be no certainty as to the timing of the Potential Disposal or that it will occur at all.

After the Transaction, the termination of the Model B clearing and settlement services and the wind down of the associated operations (as further detailed in the Announcement) the assets presently remaining in JIML (which has permissions to undertake regulated activities and hold client assets) are:

i. approximately 1,800 clients with assets under administration of circa £44 million (including circa £7 million of potentially illiquid and/or non-returnable client assets), although this is declining as assets are withdrawn;

ii. the right to receive any deferred consideration due from the Transaction;

iii. any remaining cash balances; and 

iv. the group's intellectual property (which includes the "X-O" and "Sharedeal Active" trademarks).

 

It should be noted that any proposed sale of JIML's shares and any associated change of control would be subject to, the FCA's consent. 

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis - C/O S&W Partners LLP - 0204 617 55 00 (Phil Hemming (Phil.hemming@swgroup.com) / Christopher Samson (Samson.christopher@swgroup.com))

 Zeus Capital (Nominated Adviser) - 020 3829 5000 (Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAKQBDFBKDAPK
Date   Source Headline
10th Nov 20202:56 pmRNSDividend Declaration
29th Oct 20209:30 amRNSResult of EGM
13th Oct 20207:00 amRNSCapital Reorganisation and Notice of EGM
14th Aug 20201:14 pmRNSHolding(s) in Company
6th Aug 20202:10 pmRNSDirector Declaration
30th Jul 20202:06 pmRNSDirector/PDMR Shareholding
21st Jul 202011:49 amRNSDirector/PDMR Shareholding
16th Jul 20204:08 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSHalf-year Report
6th Jul 202012:36 pmRNSBoard Changes
11th Jun 20201:44 pmRNSTransaction in Own Shares
18th May 20203:59 pmRNSDirector/PDMR Shareholding
11th May 20207:00 amRNSInterim Dividend Declaration
30th Apr 20207:00 amRNSTrading Update
23rd Apr 202012:10 pmRNSResult of AGM
14th Apr 20207:00 amRNSLetter to Shareholders
9th Apr 202011:43 amRNSHolding(s) in Company
3rd Apr 202012:56 pmRNSHolding(s) in Company
3rd Apr 202012:55 pmRNSHolding(s) in Company
3rd Apr 202012:53 pmRNSHolding(s) in Company
12th Mar 20207:00 amRNSResults for year ended 31 December 2019
11th Feb 20201:14 pmRNSDividend Declaration
30th Jan 202010:06 amRNSHolding(s) in Company
30th Jan 202010:00 amRNSHolding(s) in Company
30th Jan 20209:57 amRNSHolding(s) in Company
30th Jan 20209:56 amRNSHolding(s) in Company
18th Dec 20194:03 pmRNSHolding(s) in Company
5th Dec 201910:07 amRNSTransaction in Own Shares
26th Nov 20194:37 pmRNSTR1 - Notification of major interest in shares
25th Nov 201912:35 pmRNSDirectors' Interests
5th Nov 201911:37 amRNSDividend Declaration
22nd Oct 20193:36 pmRNSTransaction in Own Shares
17th Sep 201912:05 pmRNSDividend Declaration
5th Sep 20199:28 amRNSTransaction in Own Shares
2nd Aug 201912:22 pmRNSDividend Declaration
18th Jul 20197:00 amRNSHalf-year Report
6th Jun 20193:23 pmRNSDirector/PDMR Shareholding
7th May 201911:37 amRNSDividend Declaration
1st Apr 20193:21 pmRNSTransaction in Own Shares
29th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSFinal Results
30th Jan 20197:00 amRNSDividend Declaration
8th Nov 20187:00 amRNSDividend Declaration
3rd Aug 20182:35 pmRNSDividend Declaration
19th Jul 20187:00 amRNSInterim Results
9th May 201811:15 amRNSDividend Declaration
22nd Mar 20182:30 pmRNSResult of AGM
15th Feb 20187:00 amRNSFinal Results
8th Feb 20187:00 amRNSDividend Declaration
22nd Nov 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.